{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:46:49Z","timestamp":1785322009403,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T00:00:00Z","timestamp":1319673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10753-011-9401-x","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T09:24:42Z","timestamp":1319621082000},"page":"978-984","source":"Crossref","is-referenced-by-count":46,"title":["C-Reactive Protein and Nitric Oxide Levels in Ischemic Stroke and Its Subtypes: Correlation with Clinical Outcome"],"prefix":"10.1007","volume":"35","author":[{"given":"K.","family":"Rajeshwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Al-Hazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sai","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Balakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jyothy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,27]]},"reference":[{"issue":"4","key":"9401_CR1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/07853890009011772","volume":"32","author":"TW Clos Du","year":"2000","unstructured":"Du Clos, T.W. 2000. Function of C-reactive protein. Annals of Medicine 32(4): 274\u2013278.","journal-title":"Annals of Medicine"},{"key":"9401_CR2","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000096055.62724.C5","volume":"108","author":"P Calabro","year":"2003","unstructured":"Calabro, P., J.T. Willerson, and E.T. Yeh. 2003. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108: 1930\u20131932.","journal-title":"Circulation"},{"key":"9401_CR3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.0000029802.88087.5E","volume":"106","author":"S Verma","year":"2002","unstructured":"Verma, S., C.H. Wang, S.H. Li, A.S. Dumont, P.W.M. Fedak, M.V. Badiwala, B. Dhillon, R.D. Weisel, R. Li, D.A.G. Mickle, and D.J. Stewart. 2002. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106: 913\u2013919.","journal-title":"Circulation"},{"key":"9401_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.CIR.0000085568.13915.1E","volume":"108","author":"HD Danenberg","year":"2003","unstructured":"Danenberg, H.D., A.J. Szalai, R.V. Swaminathan, L. Peng, Z. Chen, P. Seifert, W.P. Fay, D.I. Simon, and E.R. Edelman. 2003. Increased thrombosis after arterial injury in human C-reactive proteintransgenic mice. Circulation 108: 512\u2013515.","journal-title":"Circulation"},{"key":"9401_CR5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","volume":"98","author":"PM Ridker","year":"1998","unstructured":"Ridker, P.M., J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens. 1998. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently woman. Circulation 98: 731\u2013733.","journal-title":"Circulation"},{"issue":"4","key":"9401_CR6","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/01.ATV.20.4.1052","volume":"20","author":"ES Ford","year":"2000","unstructured":"Ford, E.S., and W.H. Giles. 2000. Serum C-reactive protein and self-repoted stroke. Findings from the third National health and nutrition examination survey. Arteriosclerosis, Thrombosis, and Vascular Biology 20(4): 1052\u20131056.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9401_CR7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"PM Ridker","year":"2000","unstructured":"Ridker, P.M., C.H. Hennekens, J.E. Buring, and N. Rifai. 2000. C reactive protein and other markers of inflammation in the prediction of cardio vascular disease in women. The New England Journal of Medicine 342: 836\u2013843.","journal-title":"The New England Journal of Medicine"},{"issue":"11","key":"9401_CR8","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","volume":"32","author":"NS Rost","year":"2001","unstructured":"Rost, N.S., P.A. Wolf, C.S. Kase, M. Kelly-hayes, H. Silbershatz, J.M. Massaro, R.B. Angostino, C. Franzblau, and P.W. Wilson. 2001. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack. The Framingham study. Stroke 32(11): 2575\u20132579.","journal-title":"Stroke"},{"key":"9401_CR9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.STR.0000014206.05597.9E","volume":"33","author":"E Exel van","year":"2002","unstructured":"van Exel, E., J. Gussekloo, A.J. de Craen, A. Bootsma-vander Weil, M. Frolich, and R.G. Westendorp. 2002. Inflammation and stroke: the Leiden 85-plus study. Stroke 33: 1135\u20131138.","journal-title":"Stroke"},{"issue":"10","key":"9401_CR10","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/01.STR.0000089920.93927.A7","volume":"34","author":"JF Arenillas","year":"2003","unstructured":"Arenillas, J.F., J. Alavarez-sabin, C.A. Molinaatal, P. Chacon, J. Montaner, A. Rovira, B. Ibarra, and M. Quintana. 2003. C-reactive protein predicts further ischemic events in first-ever transient ischaemic attack or stroke patients with intracranial large artery occlusive disease. Stroke 34(10): 2463\u20132468.","journal-title":"Stroke"},{"key":"9401_CR11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","volume":"98","author":"PM Ridker","year":"1998","unstructured":"Ridker, P.M., N. Rifai, M.A. Pfeffer, F.M. Sacks, L.A. Moye, S. Goldman, G.C. Flaker, and E. Braunwald. 1998. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events (CARE) investigators. Circulation 98: 839\u2013844.","journal-title":"Circulation"},{"issue":"9050","key":"9401_CR12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","volume":"349","author":"F Haverkate","year":"1997","unstructured":"Haverkate, F., S.G. Thompson, S.D. Pyke, J.R. Gallimore, and M.B. Pepys. 1997. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349(9050): 462\u2013466.","journal-title":"Lancet"},{"issue":"2","key":"9401_CR13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(01)00595-0","volume":"160","author":"L Retterstol","year":"2002","unstructured":"Retterstol, L., L. Eikvar, M. Bohn, A. Bakken, J. Erikssen, and K. Berg. 2002. C-reactive protein predicts death in patients with previous premature myocardial infarction\u2014a 10-year follow-up study. Atherosclerosis 160(2): 433\u2013440.","journal-title":"Atherosclerosis"},{"key":"9401_CR14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.STR.30.5.981","volume":"30","author":"KW Muir","year":"1999","unstructured":"Muir, K.W., C.J. WeirJ, W. Alwan, I.B. Squire, and K.R. Lees. 1999. C-reactive protein and outcome after ischemic stroke. Stroke 30: 981\u2013985.","journal-title":"Stroke"},{"issue":"1","key":"9401_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0021-9150(99)00162-8","volume":"147","author":"CR Canova","year":"1999","unstructured":"Canova, C.R., C. Courtin, and W.H. Reinhart. 1999. C-reactive protein (CRP) in cerebro-vascular events. Atherosclerosis 147(1): 49\u201353.","journal-title":"Atherosclerosis"},{"key":"9401_CR16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.STR.31.1.231-f","volume":"31","author":"M Napoli Di","year":"2000","unstructured":"Di Napoli, M., G. Di Gianfilippo, A. Sollecito, and V. Bocola. 2000. C-reactive protein and outcome after first-ever ischemic stroke. Stroke 31: 238\u2013239.","journal-title":"Stroke"},{"key":"9401_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.STR.32.1.133","volume":"32","author":"M Napoli Di","year":"2001","unstructured":"Di Napoli, M., F. Papa, and V. Bocola. 2001. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 32: 133\u2013138.","journal-title":"Stroke"},{"issue":"4","key":"9401_CR18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-0404.2002.01224.x","volume":"106","author":"T Anuk","year":"2002","unstructured":"Anuk, T., E.B. Assayag, R. Rotstein, R. Fusman, D. Zeltser, S. Berliner, D. Avitzour, I. Shapira, N. Arber, and N.M. Bornstein. 2002. Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurologica Scandinavica 106(4): 196\u2013199.","journal-title":"Acta Neurologica Scandinavica"},{"issue":"8","key":"9401_CR19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/gerona\/57.8.M520","volume":"57","author":"E Ceccarelli","year":"2002","unstructured":"Ceccarelli, E., C. Donati, S. Forconi, R. Cappelli, and L. Masotti. 2002. C-reactive protein, physical disability, and prognosis in very old patients with ischemic stroke. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 57(8): 520\u2013522.","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"9401_CR20","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.STR.0000029828.51413.82","volume":"33","author":"K Winbeck","year":"2002","unstructured":"Winbeck, K., H. Poppert, T. Etgen, B. Conrad, and D. Sander. 2002. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 33: 2459\u20132464.","journal-title":"Stroke"},{"issue":"1\u20132","key":"9401_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-5728(03)00134-6","volume":"139","author":"HC Emsley","year":"2003","unstructured":"Emsley, H.C., C.J. Smith, C.M. Gavin, R.F. Georgiou, A. Vail, E.M. Barberan, J.M. Hallenbeck, G.J. del Zoppo, N.J. Rothwell, P.J. Tyrrell, and S.J. Hopkins. 2003. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. Journal of Neuroimmunology 139(1\u20132): 93\u2013101.","journal-title":"Journal of Neuroimmunology"},{"key":"9401_CR22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.STR.32.4.917","volume":"32","author":"M Napoli Di","year":"2001","unstructured":"Di Napoli, M., F. Papa, and V. Bocola. 2001. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32: 917\u2013924.","journal-title":"Stroke"},{"issue":"6","key":"9401_CR23","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/01.STR.0000165929.78756.ed","volume":"36","author":"M Napoli Di","year":"2005","unstructured":"Di Napoli, M., M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H.C. Emsley, S. Forconi, S.J. Hopkins, L. Masotti, K.W. Muir, A. Paciucci, F. Papa, S. Roncacci, D. Sander, K. Sander, C.J. Smith, A. Stefanini, and D. Weber. 2005. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36(6): 1316\u20131329.","journal-title":"Stroke"},{"key":"9401_CR24","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1161\/01.STR.0000231872.86071.68","volume":"37","author":"C Ladenvall","year":"2006","unstructured":"Ladenvall, C., K. Jood, C. Blomstrand, S. Nilsson, C. Jern, and P. Ladenvall. 2006. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 37: 2018\u20132023.","journal-title":"Stroke"},{"issue":"11","key":"9401_CR25","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/01.WCB.0000136517.61642.99","volume":"24","author":"R Gill","year":"2004","unstructured":"Gill, R., J.A. Kemp, C. Sabin, and M.B. Pepys. 2004. Human C-reactive protein increases cerebnan infarcet size after middle cerebnal asteny acclusion in adult rats. Journal of Cerebral Blood Flow and Metabolism 24(11): 1214\u20131218.","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"7088","key":"9401_CR26","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nature04672","volume":"440","author":"MB Pepys","year":"2006","unstructured":"Pepys, M.B., G.M. Hirshchfield, G.A. Tennent, J.R. Gallimore, M.C. Kahan, V. Bellotti, P.N. Hawkins, R.M. Myers, M.D. Smith, A. Polara, A.J. Cobb, S.V. Ley, J.A. Aquilina, C.V. Robinson, I. Sharif, G.A. Gray, C.A. Sabin, M.C. Jenvey, S.E. Kolstoe, D. Thompson, and S.P. Wood. 2006. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440(7088): 1217\u20131221.","journal-title":"Nature"},{"issue":"3","key":"9401_CR27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000079944","volume":"18","author":"H Christensen","year":"2004","unstructured":"Christensen, H., and G. Boysen. 2004. C-reactive protein and white blood cell court increases in the 24L after acute stroke. Cerebrovascular Diseases 18(3): 214\u2013219.","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"9401_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2796.2005.01514.x","volume":"258","author":"L Masotti","year":"2005","unstructured":"Masotti, L., E. Ceccarelli, S. Forconi, and R. Cappelli. 2005. Prognostic role of C-reactive protein is very old patients with acute ischemic stroke. Journal of Internal Medicine 258(2): 145\u2013152.","journal-title":"Journal of Internal Medicine"},{"issue":"5","key":"9401_CR29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/01.STR.0000217744.89208.4e","volume":"37","author":"J Montaner","year":"2006","unstructured":"Montaner, J., I. Fernandez-cadenas, C.A. Molina, M. Rib\u00f3, R. Huertas, A. Rosell, A. Penalba, L. Ortega, P. Chac\u00f3n, and J. Alvarez-Sab\u00edn. 2006. Post stroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke 37(5): 1205\u20131210.","journal-title":"Stroke"},{"issue":"8","key":"9401_CR30","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00415-008-0866-y","volume":"255","author":"R Topakion","year":"2008","unstructured":"Topakion, R., A.M. Strasak, K. Nuss baumer, H.P. Haring, and F.T. Aichner. 2008. Prognostic value of admission C-reactive protein in stroke patients undergoing iv thrombolysis. Journal of Neurology 255(8): 1190\u20131196.","journal-title":"Journal of Neurology"},{"issue":"1","key":"9401_CR31","doi-asserted-by":"crossref","first-page":"I11","DOI":"10.1002\/clc.4960261305","volume":"26","author":"P Libby","year":"2003","unstructured":"Libby, P., and M. Aikawa. 2003. Effects of statins in reducing thrombotic risk and modulating plaque vulnerability. Clinical Cardiology 26(1): I11\u2013I14.","journal-title":"Clinical Cardiology"},{"issue":"1","key":"9401_CR32","first-page":"19","volume":"77","author":"VWT Liu","year":"2008","unstructured":"Liu, V.W.T., and L.P. Huang. 2008. Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice. Cardiovascular Research 77(1): 19\u201329.","journal-title":"Cardiovascular Research"},{"issue":"1","key":"9401_CR33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1510\/icvts.2008.196428","volume":"9","author":"JD Miralles","year":"2009","unstructured":"Miralles, J.D., E. Mart\u0131\u2019nez-Aguilar, A. Florez, C. Varela, S. Bleda, and F. Acin. 2009. Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs. Interactive Cardiovascular and Thoracic Surgery 9(1): 107\u2013112.","journal-title":"Interactive Cardiovascular and Thoracic Surgery"},{"issue":"12","key":"9401_CR34","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.CIR.0000159336.31613.31","volume":"111","author":"BR Clapp","year":"2005","unstructured":"Clapp, B.R., G.M. Hirchfield, C. Storry, J.R. Galimore, R.P. Stidwilal, and M. Singer. 2005. Inflamation and endothelial function. Direct vascular effects of human C-reactive protein on nitric oxide bio-availability. Circulation 111(12): 1530\u20131536.","journal-title":"Circulation"},{"issue":"6","key":"9401_CR35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/00005344-199912000-00016","volume":"34","author":"LJ Ignarro","year":"1999","unstructured":"Ignarro, L.J., G. Cirino, A. Casini, and C. Napoli. 1999. Nitric oxide as a signaling molecule in the vascular system: an overview. Journal of Cardiovascular Pharmacology 34(6): 879\u2013886.","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"9401_CR36","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1006\/bbrc.1995.1541","volume":"209","author":"P Rhodes","year":"1995","unstructured":"Rhodes, P., A.M. Leone, P.L. Francis, A.D. Struthers, S. Moncada, and P.M. Rhodes. 1995. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochemical and Biophysical Research Communications 209(2): 590\u2013596.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1\u20132","key":"9401_CR37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2008.05.017","volume":"272","author":"A Munshi","year":"2008","unstructured":"Munshi, A., S. Shehnaz, S. Kaul, B. Pulla Reddy, S. Alladi, and A. Jyothy. 2008. Angiotensin converting enzyme insertion\/deletion polymorphism and the risk of ischemic stroke in a South Indian population. Journal of Neurological Sciences 272(1\u20132): 132\u2013135.","journal-title":"Journal of Neurological Sciences"},{"issue":"24","key":"9401_CR38","doi-asserted-by":"crossref","first-page":"14143","DOI":"10.1016\/S0021-9258(18)77279-7","volume":"265","author":"M Lepoivre","year":"1990","unstructured":"Lepoivre, M., B. Chenais, A. Yapo, G. Lemaire, L. Thelander, and J. Tenu. 1990. Alterations of ribonucleotide reductase activity follouring induction of nitrite\u2014gencrating pathway in adeno Carcinoma cells. Journal of Biological Chemistry 265(24): 14143\u201314149.","journal-title":"Journal of Biological Chemistry"},{"issue":"1\u20132","key":"9401_CR39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2006.09.011","volume":"251","author":"CJ Smith","year":"2006","unstructured":"Smith, C.J., H.C. Emsley, A. Vail, R.F. Georqiou, N.J. Rothwel, P.J. Tyrrell, and S.J. Halpkins. 2006. Varisability of the systemic acute phase response after ischemic stroke. Journal of Neurological Sciences 251(1\u20132): 77\u201381.","journal-title":"Journal of Neurological Sciences"},{"issue":"1","key":"9401_CR40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2011.03.001","volume":"217","author":"CL Chei","year":"2011","unstructured":"Chei, C.L., K. Yamagishi, A. Kitamura, M. Kiyama, H. Imano, T. Ohira, R. Cui, T. Tanigawa, T. Sankai, Y. Ishikawa, S. Sato, and H. Iso. 2011. C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 217(1): 187\u2013193.","journal-title":"Atherosclerosis"},{"issue":"7","key":"9401_CR41","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.STR.0000169924.60783.d4","volume":"36","author":"HS Markus","year":"2005","unstructured":"Markus, H.S., B. Hunt, K. Palmer, C. Enzinger, H. Schmidt, and R. Schmidt. 2005. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: Longitudinal results of the austrian Stroke Prevention Study. Stroke 36(7): 1410\u20131414.","journal-title":"Stroke"},{"issue":"4","key":"9401_CR42","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.STR.31.4.852","volume":"31","author":"J Castillo","year":"2000","unstructured":"Castillo, J., R. Rama, and A. Davalos. 2000. Nitric oxide related brain damage in acute ischemic stroke. Stroke 31(4): 852\u2013857.","journal-title":"Stroke"},{"issue":"2","key":"9401_CR43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/jscd.2003.9","volume":"12","author":"PA Rashid","year":"2003","unstructured":"Rashid, P.A., A. Whitehurst, N. Lawson, and P.M. Bath. 2003. Plasma nitric oxide (nitrate\/nitrite) levels in acute stroke and their relationship with severity and outcome. Journal of Stroke and Cerebrovascular Diseases 12(2): 82\u201387.","journal-title":"Journal of Stroke and Cerebrovascular Diseases"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-011-9401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-011-9401-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-011-9401-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,12]],"date-time":"2021-12-12T16:46:52Z","timestamp":1639327612000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-011-9401-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,27]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9401"],"URL":"https:\/\/doi.org\/10.1007\/s10753-011-9401-x","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,27]]}}}